KRT6B has been identified as a potential biomarker for differentiating between lung adenocarcinoma and lung squamous cell carcinoma, and its increased expression is associated with lower disease-free survival rates in young breast cancer patients 27, 28. The gene discussed is KRT6B; the disease is squamous cell lung carcinoma.